Medicare Enrolled

Dr. Sejan Patel, MD

Nephrology · Cary, NC
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Low-engagement
790 SE CARY PKWY STE 101, Cary, NC 27511
9192350644
In practice since 2007 (18 years)
NPI: 1417149717 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Patel from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Patel? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Patel

Dr. Sejan Patel is a nephrology specialist in Cary, NC, with 18 years of NPI registration. Based on federal Medicare data, Dr. Patel performed 1,121 Medicare services across 590 unique beneficiaries.

Between the years covered by Open Payments, Dr. Patel received a total of $3,544 from 28 pharmaceutical and/or device companies across 126 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in nephrology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Patel is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 18 years in practice ▲ 1,121 Medicare services $3,544 industry payments

Medicare Practice Summary

Medicare Utilization ↗
1,121
Medicare services
Bottom 47% in NC for nephrology
590
Unique beneficiaries
$117
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~62 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Hospital follow-up visit, moderate complexity
Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service.
393 $58 $125
Dialysis services for patients 20 or older
Dialysis treatment provided to patients aged 20 years or older, involving four or more physician visits per month.
182 $261 $630
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
117 $68 $169
Home dialysis services per month
Monthly dialysis treatment provided in the patient's home for individuals aged 20 or older.
78 $212 $525
Hemodialysis circuit intervention with balloon dilation
A procedure to insert a needle or tube into a hemodialysis circuit and dilate the dialysis segment using a balloon, with radiological review.
51 $176 $568
Sedation by physician, initial 15 minutes
Administration of a drug to induce depression of consciousness by the physician performing a procedure. This code covers the initial 15 minutes of sedation for patients aged 5 years or older.
47 $9 $30
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
41 $59 $126
Needle or tube insertion into hemodialysis circuit with radiologist review
A procedure involving the insertion of a needle or tube into a hemodialysis circuit, accompanied by a review of the procedure by a radiologist.
38 $122 $399
Balloon dilation of dialysis access with radiologist review
A minimally invasive procedure to widen a narrowed section of a dialysis access vessel using a balloon catheter. The procedure includes review by a radiologist to ensure proper placement and effectiveness.
25 $109 $347
Initial hospital admission, high complexity
Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter.
25 $127 $350
Initial hospital admission, moderate complexity
Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter.
20 $97 $250
Dialysis services for adults, 2-3 visits per month
This code covers dialysis services for patients aged 20 or older who have 2 to 3 physician visits per month.
18 $222 $525
Removal of tunneled central venous tube
This procedure involves the removal of a catheter that has been surgically placed under the skin and threaded into a large vein.
17 $99 $327
Hemodialysis, single evaluation
A dialysis procedure to filter waste from the blood, performed with a physician's evaluation.
17 $51 $150
Fluoroscopic guidance for central vein access device
Use of live X-ray imaging to guide the placement or removal of a central vein access device.
14 $14 $44
Replacement of tunneled central venous tube
This procedure involves replacing an existing tunneled central venous catheter with a new one. The new tube is inserted through the same tunnel under the skin to maintain vascular access.
13 $84 $437
Radiologist review of arm or leg artery image
A radiologist reviews images of the arteries in the arm or leg. This process involves analyzing the visual data to assess the blood vessels.
13 $62 $199
Hemodialysis circuit intervention with stent placement
A radiologist inserts a needle or tube into the hemodialysis circuit and places a stent in the dialysis segment while reviewing the procedure.
12 $224 $745
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
2.2% high complexity
36.5% medium
61.3% routine

Industry Payment Transparency

Open Payments through 2024 ↗
$3,544
Total received (2018-2024)
Avg $506/year across 7 years
Top 28% in NC for nephrology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
28
Companies
126
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$3,530 (99.6%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$13 (0.4%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$416
2023
$1,928
2022
$384
2021
$200
2020
$52
2019
$244
2018
$319

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Bard Peripheral Vascular, Inc.
$121
Amgen Inc.
$111
Otsuka America Pharmaceutical, Inc.
$82
W. L. Gore & Associates, Inc.
$43
ANI Pharmaceuticals, Inc.
$24
Boehringer Ingelheim Pharmaceuticals, Inc.
$21
GlaxoSmithKline, LLC.
$14
Top 3 companies account for 75.6% of 2024 payments
All-time payments by company (2018-2024) ›
Bard Peripheral Vascular, Inc.
$1,610
Otsuka America Pharmaceutical, Inc.
$440
Fresenius USA Marketing, Inc.
$203
Amgen Inc.
$191
W. L. Gore & Associates, Inc.
$180
NxStage Medical, Inc.
$153
Alexion Pharmaceuticals, Inc.
$69
AstraZeneca Pharmaceuticals LP
$65
Horizon Therapeutics plc
$58
GlaxoSmithKline, LLC.
$55
Keryx Biopharmaceuticals, Inc.
$52
BARD PERIPHERAL VASCULAR, INC.
$50
Aurinia Pharma U.S., Inc.
$44
Boehringer Ingelheim Pharmaceuticals, Inc.
$42
AKEBIA THERAPEUTICS INC
$38
VentureMed Group, Inc.
$37
Calliditas Therapeutics US Inc.
$36
OPKO Pharmaceuticals, LLC
$29
Vifor Pharma, Inc.
$27
ANI Pharmaceuticals, Inc.
$24
Lundbeck LLC
$23
Mallinckrodt Hospital Products Inc.
$21
Relypsa, Inc.
$21
GENZYME CORPORATION
$20
Bayer Healthcare Pharmaceuticals Inc.
$18
Janssen Pharmaceuticals, Inc
$15
RedHill Biopharma Inc.
$14
AV Medical Technologies Ltd.
$10
Top 3 companies account for 63.6% of all-time payments
Associated products mentioned in payments ›
ACTHAR · AURYXIA · Aranesp · Auryxia · BENLYSTA · COVERA · Chameleon · FABRY-DISEASE · FARXIGA · FLEX Vessel Prep System · Fluency Endovascular Stent Graft · GLIDEPATH · GORE VIABAHN Endoprosthesis · GORE VIABAHN Endoprosthesis with Heparin · JARDIANCE · JESDUVROQ · JYNARQUE · KRYSTEXXA · Kerendia · LOKELMA · LUPKYNIS · NORTHERA · NXSTAGE SYSTEM ONE · Not Product Related · PURIFIED CORTROPHIN GEL · Parsabiv · RAYALDEE · Rayaldee · SAMSCA · SOLIRIS · System One · TARPEYO · TAVNEOS · Talicia · ULTOMIRIS · VIABAHN Endoprosthesis with PROPATEN Bioactive Surface · Velphoro · Veltassa · Venovo · XARELTO
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Looking for a nephrology specialist in Cary?
Compare nephrologists in the Cary area by procedure volume, costs, and industry payment transparency.
Browse nephrologists nearby

Geographic Context

Nephrologists within 10 mi
89
Per 100K population
7.7
County median income
$101,763
Nearest hospital
WAKEMED, CARY HOSPITAL
2.4 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Patel is a clinical cardiology specialist, with moderate Medicare volume, with low-engagement industry engagement, with 18 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Patel experienced with hospital follow-up visit, moderate complexity?
Based on Medicare claims data, Dr. Patel performed 393 hospital follow-up visit, moderate complexity services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Patel receive payments from pharmaceutical companies?
Yes. Dr. Patel received a total of $3,544 from 28 companies across 126 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Patel's costs compare to other nephrologists in Cary?
Dr. Patel's average Medicare payment per service is $117. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Patel) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →